SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (5261)1/6/1998 9:58:00 PM
From: Robert K.  Respond to of 17367
 
You only beat me by minutes because I was denied access by by daughter. Its not earth shaking mistake (p2 vs p3), but it is most important trial and should be listed right. Thanks E.
Two thoughts for bedtime. 1. My theory that xoma tends to list pipleine
in order of importance. Notice trauma, then liver,then meningo. Notice liver is 2nd on list. If my theory holds true then.......
2. Curious that that little p3 was fixed but nothing else. I am curious what news is next. 7 weeks since last news. The silence is deafening. Good action on stock going nowhere today.



To: aknahow who wrote (5261)1/7/1998 4:29:00 AM
From: Tharos  Read Replies (1) | Respond to of 17367
 
George,
I think the market will respond, "Ho Hum, another PIII trial by that LOOSER Xoma." IMHO it'll take more than this to bring our ship into port ;-).